We therefore recommend subjecting all chordoid meningiomas for NGS analysis with panels containing NF2, chromatin remodeling genes, DDR genes, and if possible, TRAF7. Since some of these tumors may be mainly intraosseous, a critical point is to alert the neurosurgeon and train pathology personnel for obtaining material amenable to NGS. This evidence concerns the gene NF2 and Chordoid Meningioma.